Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
NPJ Breast Cancer ; 8(1): 107, 2022 Sep 19.
Article in English | MEDLINE | ID: mdl-36123365

ABSTRACT

This meta-analysis aimed to estimate and compare sensitivity, specificity, positive- (PPV) and negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting pathological complete remission (pCR) after neoadjuvant chemotherapy (NAC) in patients with early-stage breast cancer. We stratified for molecular subtype by immunohistochemistry (IHC) and explored the impact of other factors. Two researchers systematically searched PUBMED and EMBASE to select relevant studies and extract data. For meta-analysis of sensitivity and specificity, we used bivariate random-effects models. Twenty-six included studies contained 4497 patients. There was a significant impact of IHC subtype on post-NAC MRI accuracy (p = 0.0082) for pCR. The pooled sensitivity was 0.67 [95% CI 0.58-0.74] for the HR-/HER2-, 0.65 [95% CI 0.56-0.73] for the HR-/HER2+, 0.55 [95% CI 0.45-0.64] for the HR+/HER2- and 0.60 [95% CI 0.50-0.70] for the HR+/HER2+ subtype. The pooled specificity was 0.85 [95% CI 0.81-0.88] for the HR-/HER2-, 0.81 [95% CI 0.74-0.86] for the HR-/HER2+, 0.88[95% CI 0.84-0.91] for the HR+/HER2- and 0.74 [95% CI 0.63-0.83] for the HR+/HER2+ subtype. The PPV was highest in the HR-/HER2- subtype and lowest in the HR+/HER2- subtype. MRI field strength of 3.0 T was associated with a higher sensitivity compared to 1.5 T (p = 0.00063). The accuracy of MRI for predicting pCR depends on molecular subtype, which should be taken into account in clinical practice. Higher MRI field strength positively impacts accuracy. When intervention trials based on MRI response evaluation are designed, the impact of IHC subtype and field strength on MR accuracy should be considered.

2.
Eur J Endocrinol ; 183(4): P11-P18, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32698145

ABSTRACT

BACKGROUND: Currently, there are no European recommendations for the management of pediatric thyroid cancer. Other current international guidelines are not completely concordant. In addition, medical regulations differ between, for instance, the US and Europe. We aimed to develop new, easily accessible national recommendations for differentiated thyroid carcinoma (DTC) patients <18 years of age in the Netherlands as a first step toward a harmonized European Recommendation. METHODS: A multidisciplinary working group was formed including pediatric and adult endocrinologists, a pediatric radiologist, a pathologist, endocrine surgeons, pediatric surgeons, pediatric oncologists, nuclear medicine physicians, a clinical geneticist and a patient representative. A systematic literature search was conducted for all existing guidelines and review articles for pediatric DTC from 2000 until February 2019. The Appraisal of Guidelines, Research and Evaluation (AGREE) instrument was used for assessing quality of the articles. All were compared to determine dis- and concordances. The American Thyroid Association (ATA) pediatric guideline 2015 was used as framework to develop specific Dutch recommendations. Discussion points based upon expert opinion and current treatment management of DTC in children in the Netherlands were identified and elaborated. RESULTS: Based on the most recent evidence combined with expert opinion, a 2020 Dutch recommendation for pediatric DTC was written and published as an online interactive decision tree (www.oncoguide.nl). CONCLUSION: Pediatric DTC requires a multidisciplinary approach. The 2020 Dutch Pediatric DTC Recommendation can be used as a starting point for the development of a collaborative European recommendation for treatment of pediatric DTC.


Subject(s)
Adenocarcinoma/therapy , Pediatrics/standards , Practice Guidelines as Topic , Practice Patterns, Physicians'/statistics & numerical data , Practice Patterns, Physicians'/standards , Thyroid Neoplasms/therapy , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Age of Onset , Cell Differentiation , Child , Humans , Interdisciplinary Communication , Netherlands/epidemiology , Pediatrics/organization & administration , Pediatrics/statistics & numerical data , Thyroid Neoplasms/epidemiology , Thyroid Neoplasms/pathology
3.
Appl Radiat Isot ; 64(3): 325-32, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16290944

ABSTRACT

Here we show the first application of a microfabricated reaction system to PET radiochemistry, we term "microfluidic PET". The short half-life of the positron emitting isotopes and the trace chemical quantities used in radiolabelling make PET radiochemistry amenable to miniaturisation. Microfluidic technologies are capable of controlling and transferring tiny quantities of liquids which allow chemical and biochemical assays to be integrated and carried out on a small scale. Such technologies provide distinct advantages over current methods of PET radiochemical synthesis. To demonstrate "proof of principle" we have investigated the radiohalogenation of small and large molecular weight molecules using the microfluidic device. These reactions involved the direct radioiodination of the apoptosis marker Annexin V using iodine-124, the indirect radioiodination of the anti-cancer drug doxorubicin from a tin-butyl precursor and the radiosynthesis of 2-[(18)F]FDG from a mannose triflate precursor and fluorine-18 and hence provide a test bed for microfluidic reactions. We demonstrate the rapid radioiodination of the protein Annexin V (40% radiochemical yield within 1 min) and the rapid radiofluorination of 2-[(18)F]FDG (60% radiochemical yield within 4s) using a polymer microreactor chip. Chromatographic analysis showed that the labelling efficiency of the unoptimised microfluidic chip is comparable to conventional PET radiolabelling reactions.


Subject(s)
Bioreactors , Fluorodeoxyglucose F18/chemistry , Isotope Labeling/instrumentation , Microfluidic Analytical Techniques/instrumentation , Positron-Emission Tomography/instrumentation , Radiopharmaceuticals/chemical synthesis , Equipment Design , Equipment Failure Analysis , Feasibility Studies , Fluorodeoxyglucose F18/isolation & purification , Isotope Labeling/methods , Microfluidic Analytical Techniques/methods , Positron-Emission Tomography/methods , Radiopharmaceuticals/isolation & purification
4.
Appl Radiat Isot ; 64(3): 333-6, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16290947

ABSTRACT

This paper describes the first application of a microfabricated reaction system to positron emission tomography (PET) radiochemistry. We have applied microfluidic technology to synthesise PET radiopharmaceuticals using (18)F and (124)I as labels for fluorodeoxyglucose (FDG) and Annexin-V, respectively. These reactions involved established methods of nucleophilic substitution on a mannose triflate precursor and direct iodination of the protein using iodogen as an oxidant. This has demonstrated a proof of principle of using microfluidic technology to radiochemical reactions involving low and high molecular weight compounds. Using microfluidic reactions, [(18)F]FDG was synthesised with a 50% incorporation of the available F-18 radioactivity in a very short time of 4s. The radiolabelling efficiency of (124)I Annexin-V was 40% after 1 min reaction time. Chromatographic analysis showed that such reaction yields are comparable to conventional methods, but in a much shorter time. The yields can be further improved with more optimisation of the microfluidic device itself and its fluid mixing profiles. This demonstrates the potential for this technology to have an impact on rapid and simpler radiopharmaceutical synthesis using short and medium half-life radionuclides.


Subject(s)
Biotechnology/instrumentation , Fluorodeoxyglucose F18/chemistry , Isotope Labeling/instrumentation , Microfluidic Analytical Techniques/instrumentation , Positron-Emission Tomography/instrumentation , Radiopharmaceuticals/chemical synthesis , Biotechnology/methods , Equipment Design , Equipment Failure Analysis , Feasibility Studies , Fluorodeoxyglucose F18/isolation & purification , Isotope Labeling/methods , Microfluidic Analytical Techniques/methods , Positron-Emission Tomography/methods , Radiopharmaceuticals/isolation & purification
5.
J R Nav Med Serv ; 90(2): 70-3, 2004.
Article in English | MEDLINE | ID: mdl-15580950

ABSTRACT

DESIGN: A prospective, objective assessment of ELSA use, in order to determine whether venting of the ELSA influences carbon dioxide (CO2) levels. PRIMARY ENDPOINT: Inspired and expired CO2 levels. SETTING: On board RFA ARGUS during Operation TELIC. METHODS: 10 volunteers had a baseline of inspired and expired CO2 levels taken. These levels were measured at one minute intervals during use of an ELSA in 3 conditions--sitting, jogging and jogging with venting. RESULTS: There was no difference in expired CO2 levels between baseline and use of ELSA whilst sitting. Periodic venting of the ELSA made no difference to inspired and expired CO2 levels. CONCLUSIONS: Venting of the ELSA during use makes no difference to CO2 levels whether inspired or expired. Therefore, venting is unnecessary and potentially wastes vital time during escape from a smoke-filled compartment and adds additional stress to the escapee.


Subject(s)
Carbon Dioxide/analysis , Life Support Care/instrumentation , Naval Medicine/methods , Adult , Breath Tests , Female , Humans , Male , Middle Aged , Prospective Studies
7.
Eur J Clin Invest ; 33(2): 169-75, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12588292

ABSTRACT

BACKGROUND: Human red blood cells bind various C3b-coated microorganisms via their C3b/CR1 receptor, a phenomenon referred to as immune adherence. The aim of the present study was to measure pneumococcal adherence to human red blood cells by flow cytometry and to study kinetic aspects of this binding. MATERIAL AND METHODS: We quantified pneumococcal adherence to human erythrocytes by FACS analysis and tested the involvement of antibodies and complement activation in this process. RESULTS: Pneumococci are able to bind to human red blood cells in the presence of human serum. Coating with C3b/C4b appeared obligatory for pneumococcal adherence to red blood cells. The ligand on erythrocytes was confirmed to be complement receptor 1. Kinetic studies showed that innate (mannose-binding lectin) and specific immune factors (IgG antibodies) contributed to the binding of C3b-coated pneumococci to human erythrocytes. After initial binding, serum-derived factor I was found to induce bacterial detachment from the erythrocyte. CONCLUSIONS: Pneumococci are able to adhere to red blood cells. Both the classical and lectin complement pathways are important for optimal C3b-coating of pneumococci for immune adherence. Bound pneumococci are detached from red blood cells by factor I. These findings are in line with the hypothesis of immune adherence in which human erythrocytes are able to bind pneumococci and target the bacteria to the reticulo-endothelial system in the spleen.


Subject(s)
Bacterial Adhesion/immunology , Erythrocytes/immunology , Streptococcus pneumoniae/immunology , Cell Adhesion/immunology , Complement Activation/immunology , Complement C3b/immunology , Complement C4b/immunology , Complement Factor I/immunology , Flow Cytometry , Humans , Immune Adherence Reaction , Immunoglobulin G , Mannose-Binding Lectin/immunology , Receptors, Complement/immunology
8.
Eur Respir J ; 12(2): 374-9, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9727788

ABSTRACT

This study aimed to determine the differences in haemodynamic responses to a standard incremental exercise test between outpatients with chronic obstructive pulmonary disease (COPD) and age-matched controls and to discover the relationship between severity of airflow obstruction and exercise haemodynamics in COPD. Twenty-two male patients with COPD (forced expiratory volume in one second (FEV1)/vital capacity (VC))<80% predicted) and 20 age-matched male controls performed an incremental exercise test (10 W x min(-1)) with ventilatory function and changes in stroke volume (deltaSV) and cardiac output (deltaCO) measured by means of electrical impedance cardiography (EIC). Submaximal deltaSV and deltaCO were lower in COPD patients. Peak exercise deltaSV were equal in patients and controls (128+/-33 versus 129+/-29%, p=0.98), whereas peak deltaCO was lower in patients (COPD versus controls: 232+/-71 versus 289+/-54%, p<0.005). In COPD patients, FEV1 (% pred) was significantly correlated to deltaSV at all submaximal exercise intensities, to peak exercise deltaSV and to peak exercise deltaCO. FEV1/VC (% pred) was significantly correlated to deltaSV at 30 and 60 W. In conclusion, in chronic obstructive pulmonary disease an aberrant haemodynamic response to exercise was found, especially in patients with severe airflow obstruction. This aberrant response is related to the degree of airflow obstruction and may limit exercise performance in patients with severe chronic obstructive pulmonary disease.


Subject(s)
Exercise Tolerance/physiology , Hemodynamics/physiology , Lung Diseases, Obstructive/physiopathology , Cardiography, Impedance , Case-Control Studies , Exercise Test , Forced Expiratory Volume , Humans , Lung Diseases, Obstructive/diagnosis , Male , Middle Aged , Vital Capacity
9.
Mol Plant Microbe Interact ; 10(2): 153-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9057321

ABSTRACT

The role of the open reading frame 0 (ORF0) of luteoviruses in the viral infection cycle has not been resolved, although the translation product (p28) of this ORF has been suggested to play a role in host recognition. To investigate the function of the potato leafroll luteovirus (PLRV) p28 protein, transgenic potato plants were produced containing the ORF0. In the lines in which the ORF0 transcripts could be detected by Northern (RNA) analysis, the plants displayed an altered phenotype resembling virus-infected plants. A positive correlation was observed between levels of accumulation of the transgenic transcripts and severity of the phenotypic aberrations observed. In contrast, potato plants transformed with a modified, untranslatable ORF0 sequence were phenotypically indistinguishable from wild-type control plants. These results suggest that the p28 protein is involved in viral symptom expression. Southern blot analysis showed that the transgenic plants that accumulated low levels of ORF0 transcripts detectable only by reverse transcription-polymerase chain reaction, contained methylated ORF0 DNA sequences, indicating down-regulation of the transgene provoked by the putatively unfavorable effects p28 causes in the plant cell.


Subject(s)
Luteovirus/genetics , Luteovirus/pathogenicity , Solanum tuberosum/virology , Amino Acid Sequence , Base Sequence , DNA, Viral/genetics , Gene Expression , Genes, Viral , Molecular Sequence Data , Open Reading Frames , Phenotype , Plants, Genetically Modified , RNA, Viral/genetics , Solanum tuberosum/genetics , Viral Proteins/genetics
10.
Eur J Appl Physiol Occup Physiol ; 75(5): 435-42, 1997.
Article in English | MEDLINE | ID: mdl-9189732

ABSTRACT

Whereas with advancing age, peak heart rate (HR) and cardiac index (CI) are clearly reduced, peak stroke index (SI) may decrease, remain constant or even increase. The aim of this study was to describe the patterns of HR, SI, CI, arteriovenous difference in oxygen concentration (Ca-vO2), mean arterial pressure (MAP), systemic vascular resistance index (SVRI), stroke work index (SWI) and mean systolic ejection rate index (MSERI) in two age groups (A: 20-30 years, n = 20; B: 50-60 years n = 20). After determination of pulmonary function, an incremental bicycle exercise test was performed, with standard, gas-exchange measurements and SI assessment using electrical impedance cardiography. The following age-related changes were found: similar submaximal HR response to exercise in both groups and a higher peak HR in A than in B[185 (SD 9) vs 167 (SD 14) beats.min-1, P < 0.0005]; increase in SI with exercise up to 60-90 W and subsequent stabilization in both groups. As SI decreased towards the end of exercise in B, a higher peak SI was found in A [57.5 (SD 14.0) vs 43.6 (SD 7.7) ml.m-2, P < 0.0005]; similar submaximal CI response-to exercise, higher peak CI in A [10.6 (SD 2.5) vs 7.2 (SD 1.3) 1.min-1.m-2, P < 0.0005]; no differences in Ca-vO2 during exercise; higher MAP at all levels of exercise in B; higher SVRI at all levels of exercise in B; lower SWI in B after recovery; higher MSERI at all levels of exercise in A. The decrease in SI with advancing age would seem to be related to a decrease in myocardial contractility, which can no longer be compensated for by an increase in preload (as during submaximal exercise). Increases in systemic blood pressure may also compromise ventricular function but would seem to be of minor importance.


Subject(s)
Aging/physiology , Exercise/physiology , Hemodynamics/physiology , Adolescent , Blood Pressure/physiology , Cardiac Output/physiology , Cardiography, Impedance , Heart Rate/physiology , Humans , Male , Middle Aged , Stroke Volume/physiology , Vascular Resistance/physiology
11.
J Infect Dis ; 172(2): 562-5, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7622906

ABSTRACT

Relationships between in vitro parameters (opsonic activity and anti-pneumococcal polysaccharide [PS] antibody subclasses) and in vivo mouse protection were established by logistic regression analysis. Data were from 158 mice challenged with pneumococci after vaccination with synthetic oligosaccharide- and PS-protein conjugates in combination with the adjuvant Quil A. The hypothesis that serum opsonic activity has predictive value for protection against pneumococcal infection was tested. Serum opsonic activity was well correlated with protection (chi 2 = 35.5, P < 0.001), although a stronger correlation was observed for anti-PS IgM and IgG. The combined use of IgG and opsonic activity as predictor variables yielded the best fitting model for predicting protection (chi 2 = 74.1, P < 0.001). When opsonic activity data were added to models that included various antibody isotypes, the statistical significance of the models was enhanced. Thus, the opsonic activity of antisera induced by pneumococcal vaccines can predict mouse protection.


Subject(s)
Antibodies, Bacterial/blood , Immunoglobulin Isotypes/blood , Streptococcus pneumoniae/immunology , Adjuvants, Immunologic , Animals , Antigens, Bacterial/immunology , Bacterial Vaccines/immunology , Female , Mice , Mice, Inbred BALB C , Opsonin Proteins/blood , Pneumococcal Infections/immunology , Pneumococcal Infections/microbiology , Pneumococcal Infections/mortality , Polysaccharides, Bacterial/immunology
12.
Plant Mol Biol ; 17(1): 151-3, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1868218

ABSTRACT

Agrobacterium-mediated transformation of plants is known to result in transgenic plants with a variable number of integrated T-DNA copies. Our aim was to obtain transgenic tobacco plants containing one integrated T-DNA copy per genome. Therefore, a quick method was developed to estimate the T-DNA copy number of young transgenic plantlets within 10 weeks after transformation. Inverse polymerase chain reaction (IPCR) was used to amplify junction fragments, i.e. plant genomic DNA sequences flanking the known T-DNA sequences.


Subject(s)
DNA, Bacterial/analysis , Nicotiana/genetics , Plants, Toxic , Polymerase Chain Reaction/methods , Transformation, Genetic , Base Sequence , Molecular Sequence Data , Rhizobium/genetics
13.
Biotechnology (N Y) ; 8(3): 217-21, 1990 Mar.
Article in English | MEDLINE | ID: mdl-1366404

ABSTRACT

We have used a modified CaMV 35S promoter to direct the expression of chimaeric genes encoding human serum albumin (HSA) in transgenic potato and tobacco plants. To secrete the protein, either the human prepro-sequence or the signal sequence from the extracellular tobacco protein PR-S was used. We demonstrate secretion of HSA with both types of signal sequences in transgenic leaf tissue and in suspension cultures. HSA produced in transgenic potato plants was purified to chromatographic homogeneity. N-terminal amino acid sequence analysis revealed that the processing of the precursor protein was dependent on the type of signal sequence. Expression of the human preproHSA gene lead to partial processing of the precursor and secretion of proHSA. Fusion of HSA to the plant PR-S presequence resulted in cleavage of the presequence at its natural site and secretion of correctly processed HSA that is indistinguishable from the authentic human protein.


Subject(s)
Plants/genetics , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , Serum Albumin/biosynthesis , Transfection , Amino Acid Sequence , Base Sequence , Chimera/genetics , Humans , Molecular Sequence Data , Plants/metabolism , Plants, Toxic , Solanum tuberosum/genetics , Solanum tuberosum/metabolism , Nicotiana/genetics , Nicotiana/metabolism
15.
J Immunol Methods ; 118(1): 17-24, 1989 Mar 10.
Article in English | MEDLINE | ID: mdl-2647854

ABSTRACT

An in vitro stimulation method for the generation of hybridomas producing antibodies with specificity for the weakly immunogenic lipid A is described. Conditions influencing in vitro stimulation of immune spleen cells were investigated. Depending on the experimental conditions the percentage of specific antibody-producing hybridomas varied between 0 and 39%. Most successful was stimulation with both antigen and the synthetic adjuvant muramyl dipeptide (MDP) for 3 days. In vitro stimulation of spleen cells from animals classically immunized with Salmonella Re mutant enhanced the number of lipid A-specific IgG-producing hybridomas from six after direct fusion to 17 after stimulation. These experiments indicate that the synergistic action of antigen and MDP is caused by preferential action on antigen selected B cells.


Subject(s)
Antibodies, Monoclonal/immunology , B-Lymphocytes/immunology , Hybridomas/immunology , Lipid A/immunology , Animals , Cell Fusion , Cells, Cultured , Immunization Schedule , Immunoglobulin G/immunology , In Vitro Techniques , Lipid A/administration & dosage , Mice , Salmonella typhimurium/immunology , Spleen/immunology
16.
J Clin Microbiol ; 25(6): 1009-13, 1987 Jun.
Article in English | MEDLINE | ID: mdl-2439534

ABSTRACT

Escherichia coli O111 reacts only slightly with antiserum to its rough mutant E. coli J5 in an enzyme-linked immunosorbent assay. When E. coli O111 was grown in the presence of sub-MICs of the monocyclic beta-lactam antibiotic carumonam, however, the enzyme-linked immunosorbent assay titer increased from 1,280 to 81,920. When the bacteria were grown in the presence of carumonam, the titer that was obtained with antiserum against E. coli O111 was not affected. This reaction was abolished after this antiserum was absorbed with E. coli J5 in the case of the carumonam-treated strain, whereas this absorption did not affect the reaction with E. coli O111. Thus, the O-antigenic side chain of E. coli O111 seems to be affected if this strain is cultured in the presence of carumonam. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed a relative loss of the O polysaccharide in E. coli O111 when this strain was grown in the presence of carumonam. Also, a much stronger reaction of the antibiotic-affected lipopolysaccharide with a monoclonal antibody against E. coli J5 lipopolysaccharide was shown in immunoblots. The results of this study indicate that there is a synergism between certain antibiotics and monoclonal antibodies, something that could have clinical implications.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antibodies, Bacterial/immunology , Antibodies, Monoclonal/immunology , Aztreonam/analogs & derivatives , Escherichia coli/drug effects , Antigens, Bacterial/biosynthesis , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Escherichia coli/immunology , Immunologic Techniques , Lactams , Mutation , O Antigens
17.
EMBO J ; 5(1): 113-9, 1986 Jan.
Article in English | MEDLINE | ID: mdl-3007108

ABSTRACT

We have cloned and sequenced an adenosine deaminase (ADA) gene from a patient with severe combined immunodeficiency (SCID) caused by inherited ADA deficiency. Two point mutations were found, resulting in amino acid substitutions at positions 80 (Lys to Arg) and 304 (Leu to Arg) of the protein. Hybridization experiments with synthetic oligonucleotide probes showed that the determined mutations are present in both DNA and RNA from the ADA-SCID patient. In addition, wild-type sequences could be detected at the same positions, indicating a compound heterozygosity. Studies with ADA expression clones mutagenized in vitro showed that the mutation at position 304 is responsible for ADA inactivation.


Subject(s)
Adenosine Deaminase/genetics , Alleles , Cloning, Molecular , Genes , Immunologic Deficiency Syndromes/genetics , Mutation , Nucleoside Deaminases/genetics , Amino Acid Sequence , Animals , Arginine , Base Sequence , Cell Line , DNA Restriction Enzymes , Humans , Immunologic Deficiency Syndromes/enzymology , Leucine , Lysine , Mice , Plasmids , Species Specificity
18.
Gynecol Obstet Invest ; 22(2): 84-90, 1986.
Article in English | MEDLINE | ID: mdl-3533731

ABSTRACT

Embryonic and fetal mortality is studied, which is induced by human chorionic gonadotropin (hCG) and luteinizing hormone-releasing hormone (LHRH) given prior to ovulation. 5-day cyclic rats were injected with 20 IU hCG or with 1 microgram LHRH on day 3 of di-oestrus or on the day of pro-oestrus, and mated 4 h later. Autopsy was performed on day 3 or between days 13 and 18 of pregnancy. Advancement of ovulation by LHRH did not induce embryonic or fetal mortality. Administration of hCG at pro-oestrus or day 3 of di-oestrus induced a considerable mortality, which for the greater part occurred after day 3 of pregnancy but before implantation. This embryonic mortality could be prevented by anti-hCG serum given 21 h after hCG. It is speculated that embryonic mortality induced by hCG is caused by a relatively long-lasting disturbance of steroid metabolism, due to a long metabolic half-life of hCG. The disturbance of steroid metabolism as a possible cause of implantation failure is discussed.


Subject(s)
Chorionic Gonadotropin/adverse effects , Fetal Viability/drug effects , Animals , Diestrus , Embryonic Development , Female , Gonadotropin-Releasing Hormone/pharmacology , Ovulation/drug effects , Pregnancy , Proestrus , Rats , Rats, Inbred Strains
20.
EMBO J ; 4(2): 437-43, 1985 Feb.
Article in English | MEDLINE | ID: mdl-3839456

ABSTRACT

Cosmid clones containing the gene for human adenosine deaminase (ADA) were isolated. The gene is 32 kb long and split into 12 exons. The exact sizes and boundaries of the exon blocks including the transcription start sites were determined. The sequence upstream from this cap site lacks the TATA and CAAT boxes characteristic for eukaryotic promoters. Nevertheless, we have shown in a functional assay that a stretch of 135 bp immediately preceding the cap site has promoter activity. This 135-bp DNA fragment is extremely rich in G/C residues (82%). It contains three inverted repeats that allow the formation of cruciform structures, a 10-bp and a 16-bp direct repeat and five G/C-rich motifs (GGGCGGG) disposed in a strikingly symmetrical fashion. Some of these structural features were also found in the promoter region of other genes and we discuss their possible function. Knowledge of the exact positions of the intron-exon boundaries allowed us to propose models for abnormal RNA processing that occurs in previously investigated ADA-deficient cell lines.


Subject(s)
Adenosine Deaminase/genetics , Nucleoside Deaminases/genetics , Promoter Regions, Genetic , Base Sequence , Cells, Cultured , DNA/genetics , DNA, Recombinant , Gene Expression Regulation , Genes , Humans , Nucleic Acid Conformation , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...